1-6 of 6
Valentina L. Ivanova
Close
Sort by
Journal Articles

Ibrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell Lymphoma in Community Clinical Practice Outside of Clinical Trials

Vladimir I. Vorobyev, MD PhD, Vera A. Zherebtsova, MD PhD, Egor I. Dubrovin, Liudmila A. Bychenkova, Lev S. Butaev, Larisa A. Muha, Yulia B. Kochkareva, Valentina L. Ivanova, Eugene A. Nikitin, MD PhD Professor, Gayane Tumyan, DMSc, MD PhD, Vadim A Doronin, MD, Oleg I. Krijanovski, MD PhD, Vadim Ptushkin, MD PhD Professor
Journal: Blood
Blood (2019) 134 (Supplement_1): 5255.
https://doi.org/10.1182/blood-2019-126430
Published: 2019
Journal Articles

Incidence of Primary Immune Thrombocytopenia (ITP) in Adults in One Region of Russia

Anait L. Melikyan, MD PhD, Elena I Pustovaya, MD, Elena M. Volodicheva, Tamara I Kolosheinova, Marina V Kalinina, Ekaterina N Zotina, Ilya N Kontievskiy, Irina I Zotova, MD, Valentina L Ivanova, Yulia V Gubina, Olga M Bekker, Nadezhda V Kurkina, Irina S Sokolova, Tatiana N Babaeva, Tatiana M Sycheva, Marina T Savinova, MD, Yulia A Sedlova, Naida D Baigisheva, Varvara S Bogova, Elena A Borisenkova, Ekaterina I Kuzub, Ekaterina Yu Kalinovskaya, Michail A Rusinov, Sergei M Kulikov, PhD, Valeriy G. Savchenko, MD PhD Prof.
Journal: Blood
Blood (2016) 128 (22): 4941.
https://doi.org/10.1182/blood.V128.22.4941.4941
Published: 2016
Journal Articles

Long-Term Outcomes of Dasatinib Therapy in Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia from Physician’s and Patient’s Perspective

Tatyana I Ionova, PhD, Tatyana P Nikitina, PhD, Denis A Fedorenko, MD PhD, Taras A Gritsenko, MD PhD, Valentina L Ivanova, MD PhD, Galina B Kuchma, MD PhD, Tatyana V Shnaider, MD PhD, Inga V Sannikova, MD PhD, Elena I Usacheva, MD PhD, Kira A Kurbatova
Journal: Blood
Blood (2014) 124 (21): 2644.
https://doi.org/10.1182/blood.V124.21.2644.2644
Published: 2014
Journal Articles

Efficacy and Safety Of Pomalidomide Plus Low-Dose Dexamethasone In Advanced Multiple Myeloma: Results Of Randomized Phase 2 and 3 Trials (MM-002/MM-003)

David S. Siegel, MD, PhD, Paul G. Richardson, MD, Meletios A. Dimopoulos, MD, Christine I. Chen, MD, Kevin Song, MD, Ravi Vij, MBBS, MD, Nizar J. Bahlis, MD, Rachid Baz, MD, Craig C Hofmeister, MD, Katja Weisel, MD, Sundar Jagannath, MD, Sagar Lonial, M.D., Michel Delforge, MD, PhD, Moshe Talpaz, MD, Philippe Moreau, MD, Jesus F San Miguel, MD, PhD, Lionel Karlin, MD, Hartmut Goldschmidt, MD, Anne Banos, MD, Albert Oriol, MD, Adrian Alegre, MD, Laurent Garderet, MD, Michele Cavo, MD, Valentina L Ivanova, MD, PhD, Joaquin Martinez-Lopez, Martha Q Lacy, MD, Min Chen, PhD, Philomena Casey, Lars Sternas, MD, Mohamed H. Zaki, MD, Christian J. Jacques, MD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2013) 122 (21): 3185.
https://doi.org/10.1182/blood.V122.21.3185.3185
Published: 2013
Journal Articles

Efficacy Of Dasatinib Therapy In Patients With Imatinib-Resistant Or -Intolerant Chronic Myeloid Leukemia From Physician’s and Patient’s Perspective: “Real World” Data

Tatyana I Ionova, PhD, Tatyana P Nikitina, MD, Taras A Gritsenko, MD, PhD, Valentina L Ivanova, MD, PhD, Galina B Kuchma, MD, PhD, Tatyana V Shnaider, MD, PhD, Inga V Sannikova, MD, Denis A Fedorenko, MD, PhD, Kira A Kurbatova
Journal: Blood
Blood (2013) 122 (21): 5185.
https://doi.org/10.1182/blood.V122.21.5185.5185
Published: 2013
Journal Articles

Clinical and Patient-Reported Outcomes of Dasatinib Therapy in Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia

Tatyana I Ionova, PhD, Tatiana P Nikitina, PhD, Taras A Gritsenko, MD, PhD, Valentina L Ivanova, MD, PhD, Galina B Kuchma, MD, PhD, Tatyana V Shnaider, MD, PhD, Denis A Fedorenko, MD, PhD, Kira A Kurbatova, Andrei A Novik, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4445.
https://doi.org/10.1182/blood.V120.21.4445.4445
Published: 2012